Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY 4.0Advanced Science

CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke

6 more authors
10 affiliations
  1. 1Department of Pathophysiology Hebei Medical University Shijiazhuang People's Republic of China
  2. 2Department of Medical and Pharmaceutical Informatics Hebei Medical University Shijiazhuang People's Republic of China
  3. 3Hebei Key Laboratory of Critical Disease Mechanism and Intervention Shijiazhuang People's Republic of China
  4. 4The Key Laboratory of Neural and Vascular Biology Hebei Medical University Shijiazhuang People's Republic of China
  5. 5Foreign Languages Department Hebei Medical University Shijiazhuang People's Republic of China
  6. 6Department of Biochemistry and Molecular Biology Hebei Medical University Shijiazhuang People's Republic of China
  7. 7Department of Obstetrics The Fourth Hospital of Hebei Medical University Shijiazhuang People's Republic of China
  8. 8Transformation Center for Scientific and Technological Achievements Hebei University of Chinese Medicine Shijiazhuang People's Republic of China
  9. 9Undergraduate Student in Pediatrics Hebei Medical University Shijiazhuang People's Republic of China
  10. 10Hebei Key Laboratory of Forensic Medicine Hebei Medical University Shijiazhuang People's Republic of China

Abstract

Ischemic stroke is one of the leading causes of death and disability worldwide; yet effective therapeutic options remain limited. Cytosolic leakage of mitochondrial DNA (mtDNA) is a critical driver of ischemic brain injury. Voltage‐dependent anion channel 1 (VDAC1), embedded in the mitochondrial outer membrane, promotes mtDNA leakage through oligomerization. However, the regulatory mechanisms underlying VDAC1 oligomerization in ischemic stroke remain poorly understood. This study demonstrates that ischemic stroke promotes VDAC1 oligomerization, leading to mtDNA leakage, activating the absent in melanoma 2 (AIM2) inflammasome, and subsequent neuronal pyroptosis. Pharmacological inhibition of VDAC1 oligomerization using VBIT‐4 effectively disrupts this cascade. Creatine kinase mitochondrial 1 (CKMT1) is identified as a novel endogenous inhibitor of VDAC1 oligomerization. CKMT1 inhibits VDAC1 oligomerization through a dual‐region synergistic mechanism. Specifically, the N‐terminal domain of CKMT1 (residues R75 and E121) forms a stable interface with the C‐terminal domain of VDAC1 (residues R218 and E189), whereas the CKMT1 signal peptide (residues 1–39) sterically hinders VDAC1 dimerization, thereby blocking oligomerization. Moreover, neuronal overexpression of CKMT1 significantly attenuates neuronal apoptosis, whereas CKMT1 knockdown aggravates neuronal injury. Collectively, these findings demonstrate that CKMT1 protects against cerebral ischemic injury by suppressing the VDAC1–mtDNA–AIM2 axis and identify CKMT1 as a novel therapeutic target for ischemic stroke.

Related

  1. IL10RB-AS1 promotes pro-caspase-1-dependent pyroptosis via regulating the oligomerization and nucleation of CARD8 C-terminal domain to suppress acute myeloid leukemia
    Qi Pan, Bo He, Li-Bin Huang +18
    Cell Death & DiseasePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  2. Notoginsenoside R1 attenuates ischemic stroke via CKLF1-dependent suppression of neuronal metabolic reprogramming
    Hanlong Wang, Shasha Liu, Chen Chen +13
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCPMCEurope PMC
  3. Ligand identity and oncogenic mutations alter the oligomerization behavior of EGFR: insights from concentration-dependent brightness measurements
    Tanaya Roy, Kalina Hristova
    Journal of Biological ChemistryPeer-reviewedLicence not statedMolecular biology & gene regulationCrossref
  4. A quantitative imaging framework reveals density-dependent GPCR oligomerization and organization in living cells
    Céline Delaitre, André Dias, Nikolaj Brinkenfeldt +11
    HALPreprintLicence not statedFull textMolecular biology & gene regulationHAL
  5. OTUD4 stabilizes CYLD and counteracts BCL3 K63-linked polyubiquitination to suppress melanoma progression
    Yuming He, Lin Miao, Yunfang Deng +10
    Cell death & diseasePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCDOAJ
BibTeX
@article{wang2026ckmt1,
  title = {{CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke}},
  author = {Xiaoyu Wang and Sai Shi and Jianghui Wu and Jingge Zhang and Shuqin Li and Yuyan Hu and Haifeng Yin and Chenguang Zhao and Dong Ma and Xiaohui Xian and Lizhe Liu and Ling Zhao and Xiyun Liu and Zhikai Yu and Lihua Dong and Wenbin Li and Lingyan Zhang and Min Zhang},
  journal = {Advanced Science},
  year = {2026},
  month = nov,
  doi = {10.1002/advs.78611},
  url = {https://doi.org/10.1002/advs.78611},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke
AU  - Xiaoyu Wang
AU  - Sai Shi
AU  - Jianghui Wu
AU  - Jingge Zhang
AU  - Shuqin Li
AU  - Yuyan Hu
AU  - Haifeng Yin
AU  - Chenguang Zhao
AU  - Dong Ma
AU  - Xiaohui Xian
AU  - Lizhe Liu
AU  - Ling Zhao
AU  - Xiyun Liu
AU  - Zhikai Yu
AU  - Lihua Dong
AU  - Wenbin Li
AU  - Lingyan Zhang
AU  - Min Zhang
PY  - 2026
DA  - 2026/11/05
JO  - Advanced Science
DO  - 10.1002/advs.78611
UR  - https://doi.org/10.1002/advs.78611
AB  - Ischemic stroke is one of the leading causes of death and disability worldwide; yet effective therapeutic options remain limited. Cytosolic leakage of mitochondrial DNA (mtDNA) is a critical driver of ischemic brain injury. Voltage‐dependent anion channel 1 (VDAC1), embedded in the mitochondrial outer membrane, promotes mtDNA leakage through oligomerization. However, the regulatory mechanisms underlying VDAC1 oligomerization in ischemic stroke remain poorly understood. This study demonstrates that ischemic stroke promotes VDAC1 oligomerization, leading to mtDNA leakage, activating the absent in melanoma 2 (AIM2) inflammasome, and subsequent neuronal pyroptosis. Pharmacological inhibition of VDAC1 oligomerization using VBIT‐4 effectively disrupts this cascade. Creatine kinase mitochondrial 1 (CKMT1) is identified as a novel endogenous inhibitor of VDAC1 oligomerization. CKMT1 inhibits VDAC1 oligomerization through a dual‐region synergistic mechanism. Specifically, the N‐terminal domain of CKMT1 (residues R75 and E121) forms a stable interface with the C‐terminal domain of VDAC1 (residues R218 and E189), whereas the CKMT1 signal peptide (residues 1–39) sterically hinders VDAC1 dimerization, thereby blocking oligomerization. Moreover, neuronal overexpression of CKMT1 significantly attenuates neuronal apoptosis, whereas CKMT1 knockdown aggravates neuronal injury. Collectively, these findings demonstrate that CKMT1 protects against cerebral ischemic injury by suppressing the VDAC1–mtDNA–AIM2 axis and identify CKMT1 as a novel therapeutic target for ischemic stroke.
SN  - 2198-3844
ER  -